These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 24671522

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ, Mayo G, Price P, FitzGerald GA.
    N Engl J Med; 1991 Oct 17; 325(16):1137-41. PubMed ID: 1891022
    [Abstract] [Full Text] [Related]

  • 6. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM, Böger RH, Schubert M, Frölich JC.
    Eur J Clin Pharmacol; 1998 Oct 17; 54(9-10):707-14. PubMed ID: 9923572
    [Abstract] [Full Text] [Related]

  • 7. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA, Minar E, Brenner B, Eichler HG, Heistinger M, Marosi L, Lechner K.
    Thromb Haemost; 1989 Jun 30; 61(3):374-7. PubMed ID: 2508252
    [Abstract] [Full Text] [Related]

  • 8. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J, Mehta P, Lawson DL, Ostrowski N, Brigmon L.
    J Lab Clin Med; 1985 Sep 30; 106(3):246-52. PubMed ID: 3928780
    [Abstract] [Full Text] [Related]

  • 9. Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications.
    Spectre G, Arnetz L, Östenson CG, Brismar K, Li N, Hjemdahl P.
    Thromb Haemost; 2011 Sep 30; 106(3):491-9. PubMed ID: 21800009
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo.
    Kyrle PA, Eichler HG, Jäger U, Lechner K.
    Circulation; 1987 May 30; 75(5):1025-9. PubMed ID: 3552295
    [Abstract] [Full Text] [Related]

  • 11. Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method.
    Mizugaki M, Hishinuma T, Matsumura E, Murai Y, Yamazaki T, Yamanobe S, Tamai M.
    Prostaglandins Other Lipid Mediat; 1999 Nov 30; 58(5-6):253-62. PubMed ID: 10593167
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL, Mehta P, Lopez L, Ostrowski N, Aguila E.
    J Am Coll Cardiol; 1984 Oct 30; 4(4):806-11. PubMed ID: 6384329
    [Abstract] [Full Text] [Related]

  • 15. Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.
    Adatia I, Barrow SE, Stratton PD, Miall-Allen VM, Ritter JM, Haworth SG.
    Circulation; 1993 Nov 30; 88(5 Pt 1):2117-22. PubMed ID: 8222105
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ.
    N Engl J Med; 1981 Jan 08; 304(2):76-9. PubMed ID: 7003384
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
    Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, Orisio S, Piccinelli A, Pinciroli V, Fanelli R.
    N Engl J Med; 1989 Aug 10; 321(6):357-62. PubMed ID: 2664523
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patients with Essential Thrombocythemia may be Poor Responders to Enteric-Coated Aspirin, but not to Plain Aspirin.
    Scavone M, Rizzo J, Femia EA, Podda GM, Bossi E, Caberlon S, Paroni R, Cattaneo M.
    Thromb Haemost; 2020 Oct 10; 120(10):1442-1453. PubMed ID: 32717754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.